NEW YORK, NY / ACCESSWIRE / February 25, 2016 / As the Biotech Industry continues to face a wave of challenges, more and more investors are beginning to question whether or not it is finally time to reconsider their position. If you belong to this category of traders, ValuableInvestment.com might have the answer you are looking for. Find out how you can recover your portfolio by clicking on the link below:
http://valuableinvestment.com/insights
For more than a decade, ValuableInvestment.com and its pool of highly knowledgeable professionals have been sharing trading secrets which have helped both new and seasoned investors generate massive returns on their investments. A few days back we were at it again and we release our Top Pick for this quarter. Our team looks for pattern trades, uses disciplined techniques, and provides unique strategies so that our members can realize substantial gains trading names in various industries. See the report on or New Stock Idea now and understand why our members have been in the green for ten years now:
For today, ValuableInvestment.com has initiated alerts on the following Biotech equities: Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), Intercept Pharmaceuticals Inc. (NASDAQ: ICPT), Portola Pharmaceuticals Inc. (NASDAQ: PTLA), and Acorda Therapeutics Inc. (NYSE: ACOR).
On Wednesday, shares in Vanda Pharmaceuticals Inc. recorded a trading volume of 661,004 shares. The stock ended the day at $7.67 following a minor correction of 0.26%. The Company's shares are trading below their 50-day moving average by 12.25%. Furthermore, shares of Vanda Pharmaceuticals have a Relative Strength Index (RSI) of 36.22. Do not lose out on any VNDA's trade by activating your free access to the trade alerts now at:
http://valuableinvestment.com/VNDA
Intercept Pharmaceuticals Inc.'s stock finished yesterday's session at $112.45, down 5.73%. A total of 784,524 shares were traded, which was above its three months average volume of 690,490 shares. The Company's shares have edged 0.14% higher in the last month. The stock is trading below its 50-day moving average by 12.06%. Intercept Pharmaceuticals' stock has an RSI of 46.21. Sign up for your trade alert on ICPT at:
http://valuableinvestment.com/ICPT
On Wednesday, shares in Portola Pharmaceuticals Inc. ended the session 3.04% higher at $28.85. The stock recorded a trading volume of 1.19 million shares, above its three months average volume of 674,630 shares. Moreover, shares of Portola Pharmaceuticals have an RSI of 33.10. Register for free on ValuableInvestment.com and activate your trade alert on PTLA at:
http://valuableinvestment.com/PTLA
Acorda Therapeutics Inc.'s stock edged 0.85% lower closing the day at $33.66. The stock recorded a trading volume of 603,133 shares. The Company's shares are trading 12.78% below their 50-day moving average. Additionally, Acorda Therapeutics' stock has an RSI of 37.11. Trade Alert on ACOR is available for free at:
http://valuableinvestment.com/ACOR
--
About ValuableInvestment.com:
Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.
NO WARRANTY
ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://valuableinvestment.com
RESTRICTIONS
ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press@valuableinvestment.com
SOURCE: ValuableInvestment.com
